Wordt geladen...
Rechallenge therapy and treatment holiday: different strategies in management of metastatic colorectal cancer
Fluoropyrimidines, oxaliplatin, irinotecan and biologic therapies (Bevacizumab, Panitumumab, and Cetuximab) represent the backbone of metastatic colorectal cancer (CRC) treatment. The improvement in survival for mCRC patient led to two main outstanding issues: 1) there is a significant number of pat...
Bewaard in:
| Hoofdauteurs: | , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
BioMed Central
2013
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3874688/ https://ncbi.nlm.nih.gov/pubmed/24245912 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1756-9966-32-92 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|